Usual Care Intervention Research Evaluating the Impact of a Personalized Pharmaceutical Plan on the Duration of Opioid Treatment in Non-cancerous Pain

University Hospital, Rouen1 site in 1 country100 target enrollmentAugust 6, 2020

ConditionsNon-cancerous Pain Opioid Use

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Non-cancerous Pain
Sponsor: University Hospital, Rouen
Enrollment: 100
Locations: 1
Primary Endpoint: Total duration of opioid treatment
Status: Completed
Last Updated: 7 months ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Many treatments with WHO grade III opioids are being introduced in the rheumatology department for non-cancerous pain. The duration of this treatment prescribed at discharge is often uncontrolled and sometimes leads to significant addiction.

The team at the local pain center recommends an average duration of 28 days for this type of pain. There is a full-time pharmacy intern in the rheumatology department.

The aim of this work is to evaluate the impact of a targeted pharmaceutical interview on the duration of the morphine treatment initiated during hospitalization.

Registry

clinicaltrials.gov

Start Date

August 6, 2020

End Date

August 28, 2023

Last Updated

7 months ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

University Hospital, Rouen

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Age ≥ 18 and \< 75 years old when entering the rheumatology department
•Hospitalization in the rheumatology department
•Patient with acute non-traumatic musculoskeletal disease
•Patient not taking grade III opioid treatment
•Patient affiliated to a social security scheme
•Patient having read and understood the information letter and signed the consent form
•Patient present on a day which the pharmacy intern is present

Exclusion Criteria

•Presence of cancer, fibromyalgia, already diagnosed at inclusion
•Patient does not understand French
•Patient with Current or past opioid addiction
•Person deprived of liberty by administrative or judicial decision

Outcomes

Primary Outcomes

Total duration of opioid treatment

Time Frame: 6 months

Secondary Outcomes

Rate of patients exceeding 28 days of cumulative duration of treatment(6 months)
Rate of patients exceeding 90 days of cumulative duration of treatment(6 months)